Lindsay Feldman had given up hope of having any more children. Then the 39-year-old started taking a popular weight-loss drug - and just ten months later she was pregnant.

From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side ...

In the latest bunch of recommendations from the European Medicines | Sanofi, Novo Nordisk, UCB and others received positive ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...

Health chiefs have warned that GLP-1 medication increases risk of developing severe inflammation of the pancreas - which can ...

As Canada prepares for generic weight-loss drugs, the benefits for metabolic diseases come with weightier expectations that we should all be skinny ...

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.

Compounded semaglutide - the active ingredient in the blockbuster drugs mixed with other additives - is produced by ...

Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also Zepbound, Mounjaro, Trulicity and Victoza — and many more on the horizon ...

Wegovy tablets offer a daily oral alternative to injections for weight reduction and reducing cardiovascular risk in eligible adult patients.